These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 10928129

  • 1. Expression of p53 and p21 is useful for the prediction of preoperative chemotherapeutic effects in esophageal carcinoma.
    Nakashima S, Natsugoe S, Matsumoto M, Kijima F, Takebayashi Y, Okumura H, Shimada M, Nakano S, Kusano C, Baba M, Takao S, Aikou T.
    Anticancer Res; 2000; 20(3B):1933-7. PubMed ID: 10928129
    [Abstract] [Full Text] [Related]

  • 2. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2005; 25(4):2749-55. PubMed ID: 16080521
    [Abstract] [Full Text] [Related]

  • 3. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H, Natsugoe S, Matsumoto M, Yokomakura N, Uchikado Y, Takatori H, Ishigami S, Takao S, Aikou T.
    J Surg Oncol; 2005 Jul 01; 91(1):84-9. PubMed ID: 15999354
    [Abstract] [Full Text] [Related]

  • 4. Predictive effect of p53 and p21 alteration on chemotherapy response and survival in locally advanced adenocarcinoma of the esophagus.
    Heeren PA, Kloppenberg FW, Hollema H, Mulder NH, Nap RE, Plukker JT.
    Anticancer Res; 2004 Jul 01; 24(4):2579-83. PubMed ID: 15330218
    [Abstract] [Full Text] [Related]

  • 5. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR, Tucker SA, Huang Z, Gillenwater AM, Luna MA, Batsakis JG, El-Naggar AK.
    Int J Oncol; 2003 Feb 01; 22(2):409-14. PubMed ID: 12527941
    [Abstract] [Full Text] [Related]

  • 6. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG, Hsu HK, Chang HC, Chou YP, Chiang KH, Cheng JT.
    Ann Thorac Surg; 2005 Sep 01; 80(3):1007-16. PubMed ID: 16122475
    [Abstract] [Full Text] [Related]

  • 7. Expression of p21WAF1/Cip1 in the p53-dependent pathway is related to prognosis in patients with advanced esophageal carcinoma.
    Natsugoe S, Nakashima S, Matsumoto M, Xiangming C, Okumura H, Kijima F, Ishigami S, Takebayashi Y, Baba M, Takao S, Aikou T.
    Clin Cancer Res; 1999 Sep 01; 5(9):2445-9. PubMed ID: 10499617
    [Abstract] [Full Text] [Related]

  • 8. p53, p21 and p27 protein expression in head and neck cancer and their prognostic value.
    Kapranos N, Stathopoulos GP, Manolopoulos L, Kokka E, Papadimitriou C, Bibas A, Yiotakis J, Adamopoulos G.
    Anticancer Res; 2001 Sep 01; 21(1B):521-8. PubMed ID: 11299798
    [Abstract] [Full Text] [Related]

  • 9. Expression and alteration of p53 and p21(waf1/cip1) influence the sensitivity of chemoradiation therapy for esophageal cancer.
    Shimoyama S, Konishi T, Kawahara M, Aoki F, Harada N, Shimizu S, Murakami T, Kaminishi M.
    Hepatogastroenterology; 1998 Sep 01; 45(23):1497-504. PubMed ID: 9840093
    [Abstract] [Full Text] [Related]

  • 10. Clinical benefit of chemosensitivity test for patients with regional lymph node-positive esophageal squamous cell carcinoma.
    Nakamori M, Iwahashi M, Nakamura M, Yamaue H.
    J Surg Oncol; 2003 Sep 01; 84(1):10-6. PubMed ID: 12949985
    [Abstract] [Full Text] [Related]

  • 11. Prognostic significance of p21 protein expression in patients with pulmonary squamous cell carcinoma following induction chemotherapy.
    Tamura M, Sawabata N, Kobayashi S, Umezu H, Seki N, Yoshii N, Karube Y, Araki O, Ishihama H, Nagai S, Miyoshi S.
    Ann Thorac Cardiovasc Surg; 2007 Feb 01; 13(1):9-14. PubMed ID: 17392664
    [Abstract] [Full Text] [Related]

  • 12. p53 genotype predicts response to chemotherapy in patients with squamous cell carcinoma of the esophagus.
    Yamasaki M, Miyata H, Fujiwara Y, Takiguchi S, Nakajima K, Nishida T, Yasuda T, Matsuyama J, Mori M, Doki Y.
    Ann Surg Oncol; 2010 Feb 01; 17(2):634-42. PubMed ID: 19941080
    [Abstract] [Full Text] [Related]

  • 13. The prognostic significance of p53, p21 (Waf1/Cip1), and cyclin D1 protein expression in esophageal cancer patients.
    Hirai T, Kuwahara M, Yoshida K, Osaki A, Toge T.
    Anticancer Res; 1999 Feb 01; 19(5C):4587-91. PubMed ID: 10650815
    [Abstract] [Full Text] [Related]

  • 14. Adjuvant chemotherapy with 5-fluorouracil and cisplatin in lymph node-positive thoracic esophageal squamous cell carcinoma.
    Lee J, Lee KE, Im YH, Kang WK, Park K, Kim K, Shim YM.
    Ann Thorac Surg; 2005 Oct 01; 80(4):1170-5. PubMed ID: 16181835
    [Abstract] [Full Text] [Related]

  • 15. Neoadjuvant chemotherapy with etoposide, leucovorin, 5-fluorouracil and cisplatin for advanced esophageal squamous cell carcinoma.
    Ohwada S, Nakamura S, Izumi M, Kawashima Y, Ogawa T, Kobayashi I, Hosomura Y, Joshita T, Lino Y, Morishita Y.
    Jpn J Clin Oncol; 1995 Jun 01; 25(3):79-85. PubMed ID: 7596052
    [Abstract] [Full Text] [Related]

  • 16. p21 expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung.
    Komiya T, Hosono Y, Hirashima T, Masuda N, Yasumitsu T, Nakagawa K, Kikui M, Ohno A, Fukuoka M, Kawase I.
    Clin Cancer Res; 1997 Oct 01; 3(10):1831-5. PubMed ID: 9815570
    [Abstract] [Full Text] [Related]

  • 17. Prediction of lymph node metastasis by p53, p21(Waf1), and PCNA expression in esophageal cancer patients.
    Ueno H, Hirai T, Nishimoto N, Hihara J, Inoue H, Yoshida K, Yamashita Y, Toge T, Tsubota N.
    J Exp Clin Cancer Res; 2003 Jun 01; 22(2):239-45. PubMed ID: 12866574
    [Abstract] [Full Text] [Related]

  • 18. p53 and p21 Expression levels predict organ preservation and survival in invasive bladder carcinoma treated with a combined-modality approach.
    Garcia del Muro X, Condom E, Vigués F, Castellsagué X, Figueras A, Muñoz J, Solá J, Soler T, Capellà G, Germà JR.
    Cancer; 2004 May 01; 100(9):1859-67. PubMed ID: 15112266
    [Abstract] [Full Text] [Related]

  • 19. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, Fracchioli S, Durando A, Arisio R, Diamandis EP.
    Clin Cancer Res; 2000 Aug 01; 6(8):3260-70. PubMed ID: 10955812
    [Abstract] [Full Text] [Related]

  • 20. The nm23-H1 gene as a predictor of sensitivity to chemotherapeutic agents in oesophageal squamous cell carcinoma.
    Iizuka N, Hirose K, Noma T, Hazama S, Tangoku A, Hayashi H, Abe T, Yamamoto K, Oka M.
    Br J Cancer; 1999 Oct 01; 81(3):469-75. PubMed ID: 10507772
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.